Cubist Systematic Strategies, LLC Sorrento Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $55,161 - $136,411	74,542 Added 8.88%	914,286 $813,000
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $16,104 - $30,715	10,665 Added 1.29%	839,744 $1.32 Million
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $734,921 - $1.38 Million	592,679 Added 250.71%	829,079 $1.67 Million
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $440,418 - $1.08 Million	220,209 Added 1360.07%	236,400 $551,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $75,288 - $117,060	16,191 New	16,191 $75,000
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $155,817 - $231,097	-21,028 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $133,527 - $210,280	21,028 New	21,028 $204,000
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $163,209 - $338,603	-28,335 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$6.17 - $18.82 $1.83 Million - $5.58 Million	-296,265 Reduced 91.27%	28,335 $316,000
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $561,558 - $2.19 Million	324,600 New	324,600 $2.04 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.